Global In Vitro Toxicity Testing Market – Major Players
Major players operating in the global in vitro toxicity testing market include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences, Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Société Générale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
Global In Vitro Toxicity Testing Market: Key Developments
Strict regulations banning animal testing are expected to offer lucrative growth for players in the global in vitro toxicity market. For instance, in January 2020, the state governments of California, Nevada, and Illinois banned the sale or import of animal-tested cosmetics.
Major players in the market are focused on adopting Merger and and acquisition strategies to expand their product portfolio. For instance, in April 2020, Bio-Rad Laboratories, Inc., a developer and manufacturer of specialized technological products acquired Celsee, Inc., a developer of instruments and consumables for the isolation, detection, and analysis of single cells.
Global In Vitro Toxicity Testing Market - Key Players
Major players operating in the global in vitro toxicity testing market include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences, Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Société Générale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients